ATAI Life Sciences N.V (NASDAQ:ATAI) price on Thursday, March 20, fall -1.44% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $1.37.
A look at the stock’s price movement, the close in the last trading session was $1.39, moving within a range at $1.33 and $1.48. The beta value (5-Year monthly) was 1.186. Turning to its 52-week performance, $2.85 and $1.03 were the 52-week high and 52-week low respectively. Overall, ATAI moved -34.45% over the past month.
ATAI Life Sciences N.V’s market cap currently stands at around $265.77 million, with investors looking forward to this quarter’s earnings report slated for on 2025-Mar-16.
Wall Street analysts have also projected the company’s year-on-year revenue to grow to 250k, representing a -18.83% decline on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that ATAI is a 50% Sell. On the other hand, the stock is on average a 50% Buy as suggested by medium term indicators while long term indicators are putting the stock in 50% Sell category.
1 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 1 recommend ATAI as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
ATAI’s current price about -11.88% and -19.71% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 38.64, while 7-day volatility ratio is 7.48% and 9.17% in the 30-day chart. Further, ATAI Life Sciences N.V (ATAI) has a beta value of 1.24, and an average true range (ATR) of 0.16. Analysts have given the company’s stock an average 52-week price target of $6, forecast between a low of $6 and high of $6. Looking at the price targets, the low is -337.96% off current price level while to achieve the yearly target high, price needs to move -337.96%. Nonetheless, investors will most likely welcome a -337.96% jump to $6 which is the analysts’ median price.
If we refocus on ATAI Life Sciences N.V (NASDAQ:ATAI), historical trading data shows that trading volumes averaged 1.66 over the past 10 days and 2.85 million over the past 3 months. The company’s latest data on shares outstanding shows there are 167.82 million shares.
The 32.09% of ATAI Life Sciences N.V’s shares are in the hands of company insiders while institutional holders own 7.50% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 10.96 million on 2025-02-28, giving us a short ratio of 2.38. The data shows that as of 2025-02-28 short interest in ATAI Life Sciences N.V (ATAI) stood at 710.0 of shares outstanding, with shares short falling to 11.31 million registered in 2025-01-31. Current price change has pushed the stock 3.01% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the ATAI stock continues to rise going into the next quarter.